Poster abstracts
Poster number 103 submitted by Madhura Paranjpe
Insights into the molecular mechanism of translation inhibition by the ribosome-targeting antibiotic thermorubin
Madhura N Paranjpe, Yury S. Polikanov (Department of Biological Sciences, University of Illinois at Chicago), Valeria I. Marina, Tinashe P. Maviza , Ilya A. Osterman , Petr V. Sergiev (Department of Chemistry and Institute of Functional Genomics, Lomonosov Moscow State University), Aleksandr A. Grachev, Olga A. Tolicheva, Alena Paleskava (Peter the Great St.Petersburg Polytechnic University, Saint Petersburg 195251, Russia, 4Department of Pharmaceutical Sciences, University of Illinois at Chicago), Yury S. Polikanov (Department of Chemistry and Institute of Functional Genomics, Lomonosov Moscow State University), Andrey L. Konevega (Peter the Great St.Petersburg Polytechnic University, Saint Petersburg 195251, Russia, 4Department of Pharmaceutical Sciences, University of Illinois at Chicago), Matthieu G. Gagnon (Center for Biomolecular Sciences, University of Illinois at Chicago, Chicago, IL 60607, USA,)
Abstract:
Thermorubin (THR) is an aromatic anthracenopyranone antibiotic active against both Gram-positive and Gram-negative bacteria. It is known to bind to the 70S ribosome at the intersubunit bridge B2a and was thought to inhibit factor-dependent initiation of translation and obstruct the accommodation of tRNAs into the A site. Here, we show that thermorubin causes ribosomes to stall in vivo and in vitro at internal and termination codons, thereby allowing the ribosome to initiate protein synthesis and translate at least a few codons before stalling. Our biochemical data show that THR affects multiple steps of translation elongation with a significant impact on the binding stability of the tRNA in the A site, explaining premature cessation of translation. Our high-resolution crystal and cryo-EM structures of the 70S-THR complex show that THR can co-exist with P- and A-site tRNAs, explaining how ribosomes can elongate in the presence of the drug. Remarkable is the ability of THR to arrest ribosomes at the stop codons. Our data suggest that by causing structural re-arrangements in the decoding center, THR interferes with the accommodation of tRNAs or release factors into the ribosomal A site.
Keywords: Thermorubin , Ribosome, Translation inhibitor